Cargando…

1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital

BACKGROUND: Shortly after its introduction into clinical practice, Staphylococcus aureus isolates gained resistance to penicillin via the acquisition of β-lactamases. By the 1960s, these strains became the dominant staphylococci in clinical practice. However, a number of centers have recently descri...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeil Jonathon, C, Sommer, Lauren M, Joseph, Marritta, Hulten, Kristina G, Kaplan, Sheldon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752129/
http://dx.doi.org/10.1093/ofid/ofac492.1154
_version_ 1784850644174110720
author McNeil Jonathon, C
Sommer, Lauren M
Joseph, Marritta
Hulten, Kristina G
Kaplan, Sheldon L
author_facet McNeil Jonathon, C
Sommer, Lauren M
Joseph, Marritta
Hulten, Kristina G
Kaplan, Sheldon L
author_sort McNeil Jonathon, C
collection PubMed
description BACKGROUND: Shortly after its introduction into clinical practice, Staphylococcus aureus isolates gained resistance to penicillin via the acquisition of β-lactamases. By the 1960s, these strains became the dominant staphylococci in clinical practice. However, a number of centers have recently described an increase in the proportion of methicillin susceptible S. aureus (MSSA) which are also susceptible to penicillin (PSSA). In our center we have recently observed the emergence of PSSA in osteoarticular infections. Little data are available regarding the prevalence or impact of PSSA in pediatric skin-and-soft-tissue infections (SSTI). METHODS: MSSA SSTI isolates were obtained through an ongoing surveillance study at Texas Children’s (TCH) from 1/2017-12/2021. Twenty community-acquired MSSA SSTI isolates were chosen at random from every six-month interval during the study period, for a total of 200 isolates to be screened. All isolates underwent PCR for blaZ β-lactamase, PVL genes and agr group. All blaZ negative isolates then underwent penicillin susceptibility testing using macrobroth dilution. Isolates which were blaZ negative and had a penicillin MIC ≤ 0.125 μg/ml were regarded as PSSA with the remainder regarded as penicillin-resistant MSSA (PR-MSSA). RESULTS: During the study period 1701 MSSA SSTI isolates were collected with 200 examined for penicillin susceptibility. The overall median age of subjects was 4.1 years (IQR: 1.6-10.4). PSSA accounted for 9% of isolates during the study period; the annual frequency of PSSA varied from 5-17.5%. PSSA and PR-MSSA cases were similar with respect to age, demographics, anatomic site of infection and rates of prior antibiotic exposure. Subjects with SSTI secondary to PSSA more often had a prior history of SSTI, a diagnosis of abscess and were more often admitted to the hospital (Figure). Among PSSA, 94.4% belonged to agrI and 33.3% were PVL positive. Penicillin-Susceptible S. aureus (PSSA) vs. Penicillin-Resistant Methicillin-Susceptible S. aureus (PR-MSSA) Pediatric SSTI Isolates [Figure: see text] Comparison of the clinical features of PSSA and PR-MSSA SSTI isolates. PSSA were significantly associated with the diagnosis of abscess as well as hospital admission. CONCLUSION: PSSA account for a small but significant proportion of MSSA SSTI in children. Clinically distinguishing patients with PSSA and PR-MSSA is challenging. However, PSSA SSTI were associated with a greater rate of abscess formation and hospital admission, suggesting a high clinical impact of these infections. Further studies are needed to understand the optimal management of these infections. DISCLOSURES: Jonathon C. McNeil, MD, Agency for Healthcare Research and Quality: Grant/Research Support|Allergan: Provided reagents for unrelated research|Nabriva: Site investigator for multicenter clinical trial Kristina G. Hulten, PhD, Me-med: Grant/Research Support|Pfizer: Grant/Research Support Sheldon L. Kaplan, MD, MeMed: Grant/Research Support|Pfizer: Grant/Research Support.
format Online
Article
Text
id pubmed-9752129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97521292022-12-16 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital McNeil Jonathon, C Sommer, Lauren M Joseph, Marritta Hulten, Kristina G Kaplan, Sheldon L Open Forum Infect Dis Abstracts BACKGROUND: Shortly after its introduction into clinical practice, Staphylococcus aureus isolates gained resistance to penicillin via the acquisition of β-lactamases. By the 1960s, these strains became the dominant staphylococci in clinical practice. However, a number of centers have recently described an increase in the proportion of methicillin susceptible S. aureus (MSSA) which are also susceptible to penicillin (PSSA). In our center we have recently observed the emergence of PSSA in osteoarticular infections. Little data are available regarding the prevalence or impact of PSSA in pediatric skin-and-soft-tissue infections (SSTI). METHODS: MSSA SSTI isolates were obtained through an ongoing surveillance study at Texas Children’s (TCH) from 1/2017-12/2021. Twenty community-acquired MSSA SSTI isolates were chosen at random from every six-month interval during the study period, for a total of 200 isolates to be screened. All isolates underwent PCR for blaZ β-lactamase, PVL genes and agr group. All blaZ negative isolates then underwent penicillin susceptibility testing using macrobroth dilution. Isolates which were blaZ negative and had a penicillin MIC ≤ 0.125 μg/ml were regarded as PSSA with the remainder regarded as penicillin-resistant MSSA (PR-MSSA). RESULTS: During the study period 1701 MSSA SSTI isolates were collected with 200 examined for penicillin susceptibility. The overall median age of subjects was 4.1 years (IQR: 1.6-10.4). PSSA accounted for 9% of isolates during the study period; the annual frequency of PSSA varied from 5-17.5%. PSSA and PR-MSSA cases were similar with respect to age, demographics, anatomic site of infection and rates of prior antibiotic exposure. Subjects with SSTI secondary to PSSA more often had a prior history of SSTI, a diagnosis of abscess and were more often admitted to the hospital (Figure). Among PSSA, 94.4% belonged to agrI and 33.3% were PVL positive. Penicillin-Susceptible S. aureus (PSSA) vs. Penicillin-Resistant Methicillin-Susceptible S. aureus (PR-MSSA) Pediatric SSTI Isolates [Figure: see text] Comparison of the clinical features of PSSA and PR-MSSA SSTI isolates. PSSA were significantly associated with the diagnosis of abscess as well as hospital admission. CONCLUSION: PSSA account for a small but significant proportion of MSSA SSTI in children. Clinically distinguishing patients with PSSA and PR-MSSA is challenging. However, PSSA SSTI were associated with a greater rate of abscess formation and hospital admission, suggesting a high clinical impact of these infections. Further studies are needed to understand the optimal management of these infections. DISCLOSURES: Jonathon C. McNeil, MD, Agency for Healthcare Research and Quality: Grant/Research Support|Allergan: Provided reagents for unrelated research|Nabriva: Site investigator for multicenter clinical trial Kristina G. Hulten, PhD, Me-med: Grant/Research Support|Pfizer: Grant/Research Support Sheldon L. Kaplan, MD, MeMed: Grant/Research Support|Pfizer: Grant/Research Support. Oxford University Press 2022-12-15 /pmc/articles/PMC9752129/ http://dx.doi.org/10.1093/ofid/ofac492.1154 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
McNeil Jonathon, C
Sommer, Lauren M
Joseph, Marritta
Hulten, Kristina G
Kaplan, Sheldon L
1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title_full 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title_fullStr 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title_full_unstemmed 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title_short 1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
title_sort 1324. penicillin-susceptibility among staphylococcus aureus skin-and-soft-tissue infections at a children’s hospital
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752129/
http://dx.doi.org/10.1093/ofid/ofac492.1154
work_keys_str_mv AT mcneiljonathonc 1324penicillinsusceptibilityamongstaphylococcusaureusskinandsofttissueinfectionsatachildrenshospital
AT sommerlaurenm 1324penicillinsusceptibilityamongstaphylococcusaureusskinandsofttissueinfectionsatachildrenshospital
AT josephmarritta 1324penicillinsusceptibilityamongstaphylococcusaureusskinandsofttissueinfectionsatachildrenshospital
AT hultenkristinag 1324penicillinsusceptibilityamongstaphylococcusaureusskinandsofttissueinfectionsatachildrenshospital
AT kaplansheldonl 1324penicillinsusceptibilityamongstaphylococcusaureusskinandsofttissueinfectionsatachildrenshospital